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Abstract
Background: In middle income countries, the burden of rheumatic heart disease (RHD) remains high, but the prevalence of
other heart valve diseases may rise as the population life expectancy increases. Here, we compared population-based data
on surgical procedures to assess the relative importance of causes of heart valve disease in Salvador, Brazil.
Methodology/Principal Findings: Medical charts of patients who underwent surgery for valvular heart disease from January
2002–December 2005 were reviewed. Incidence of surgery for valvular heart disease was calculated. Logistic regression was
used to identify factors associated with in-hospital death following surgery. The most common etiologies for valvular
dysfunction in 491 valvular heart surgery patients were RHD (60.3%), degenerative valve disease (15.3%), and endocarditis
(4.5%). Mean annual incidence for surgeries due to any valvular heart diseases, RHD, and degenerative valvular disease were
5.02, 3.03, and 0.77 per 100,000 population, respectively. Incidence of surgery due to RHD was highest in young adults;
procedures were predominantly paid by the public health sector. In contrast, the incidence of surgery due to degenerative
valvular disease was highest among those older than 60 years of age; procedures were mostly paid by the private sector.
The overall in-hospital case-fatality ratio was 11.9%. Independent factors associated with death included increase in age
(odds ratio: 1.04 per year of age; 95% confidence interval: 1.02–1.06), endocarditis (6.35; 1.92–21.04), multiple valve
operative procedures (4.35; 2.12–8.95), and prior heart valve surgery (2.49; 1.05–5.87).
Conclusions/Significance: RHD remains the main cause for valvular heart surgery in Salvador, which primarily affects young
adults without private health insurance. In contrast, surgery due to degenerative valvular disease primarily impacts the
elderly with private health insurance. Strategies to reduce the burden of valvular heart disease will need to address the
disparate factors that contribute to RHD as well as degenerative valve disease.
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Introduction
The global epidemiology of valvular heart disease has changed
dramatically in the past century [1–3]. Worldwide, rheumatic
heart disease (RHD) was the leading cause of valvular disease
before World War II. However, the introduction of antibiotics and
improved access to health care contributed to a substantial
reduction in the incidence of RHD in the second half of the 20
th
century in developed countries [4]. At the same time, life-
expectancy has increased and the prevalence of age-related
valvular diseases (e.g. degenerative valvular disease) increased.
Degenerative valvular disease is now the most common valvular
disease in developed countries [4]. In the United States, it is
estimated that 2.5% of the general population, 8.5% of those 65–
74 years of age and 13.2% of those $75 years of age have
moderate to severe valvular disease [5].
In contrast, RHD remains the leading cause of valvular disease
in developing countries [6]. It has been estimated that 79% of the
15.6 to 19.6 million people alive with RHD today live in
developing countries [7]. These numbers likely underestimate the
true burden of RHD worldwide because they are based on
prevalence data obtained from clinical screening followed by
echocardiography, rather than by echocardiography screening of
all surveyed subjects [8].
Surgical intervention is the predominant treatment for moder-
ate to severe valvular heart disease. Although this option is costly,
access to advanced medical procedures increases with economic
development. Brazil is an example of a country which has
undergone substantial growth as the result of social and economic
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to increased life expectancy [10]. Additionally, the Brazilian public
health system (Sistema U ´nico de Sau ´de, SUS) which provides
universal medical care, was introduced in 1988. The mean
number of valve surgeries performed at the largest Brazilian public
cardiovascular hospital in Sa ˜o Paulo increased 50%, from 400 to
600 surgeries per year between the 19809s and the 20009s [11].
As Brazil develops, a gradual decrease in the prevalence of
RHD and an increase in the prevalence of degenerative valvular
disease are expected. However, few population-based studies have
investigated the burden of cardiac valvular disease in emerging
economy countries [6,7]. Herein, we present data from a
population-based study conducted in Salvador, Brazil to deter-
mine the incidence and the most common etiologies for valvular
heart dysfunctions requiring surgical intervention. In addition, we
determined risk factors for in-hospital death following valve
surgery.
Methods
Study Design
We performed a retrospective population-based study of
patients who underwent cardiac valve surgery in the city of
Salvador, Brazil, between January 1, 2002 and December 31,
2005. Salvador is the third largest city in Brazil (population
2,520,505 in 2002) [12] and is the only city in the state where
cardiac surgery is performed. All cardiac surgeries in the city were
performed by five cardiac surgery teams, working within six large
hospitals (.250 beds each). Of these hospitals, four were
philanthropic, one was private, and one was part of a public
university. Cardiac surgeries were paid for by the Brazilian public
health system, by private health insurance, or infrequently by the
patient.
Data Collection and Definitions
Surgery registries in cardiac surgery units were reviewed to
identify patients who fulfilled the study inclusion criteria: living in
the city of Salvador and undergoing opened aortic, mitral, or
tricuspid valve repair or replacement during the study period.
Valve repair included procedures with or without ring annulo-
plasty. Patients undergoing valve repair simultaneous to another
cardiac procedure, such as revascularization, were included in the
study. Patients undergoing non-valvular cardiac surgeries were
excluded from the study. A standardized case report form was
used to collect the following data: date of surgery, city of residence
at the time of surgery, age at surgery, sex, health insurance
payment plan, procedure (valve repair and/or replacement),
operated valve, and within hospital outcome (discharge or death).
Medical charts of patients who fulfilled the inclusion criteria
were solicited from five of the six hospitals for review. One of the
philanthropic hospitals was excluded from the medical chart
review because only two cardiac valve surgeries had been
performed there during the study period. Medical chart review
and data extraction were performed. Previously collected data
were confirmed and additional data on race, previous cardiac
valve surgeries, valve disease etiology and type of prosthesis used
(mechanical and/or biological) were collected using a standardized
intake form.
Etiology for valvular dysfunction was ascertained based on
information from one of the following sections of the medical
chart: diagnosis, prior medical history, or echocardiography
findings. Patients with mitral or aortic stenosis or regurgitation
who presented with a thickened valve compatible with RHD at
echocardiography, or who had a history of previous acute
rheumatic fever were defined as cases of RHD. Patients with
calcific stenosis of the three or two cusp aortic valves or with mitral
annular calcification without an underlying immunologic or
inflammatory disease, such as acute rheumatic fever, were defined
as cases of degenerative valve disease. Patients with echocardio-
graphic or surgical evidence of valve vegetation, or intramural
abscess were defined as cases of infective endocarditis. Patients
who simultaneously fulfilled the definitions for RHD and
endocarditis were classified as having RHD.
Ethics
Research protocol approval was obtained from all five hospitals
where medical chart reviews were conducted; the Research Ethical
Committee from Gonc ¸alo Moniz Research Center, Oswaldo Cruz
Foundation; the Brazilian National Commission for Ethics in
Research (CONEP); and the University of California, Berkeley
Committee for the Protection of Human Subjects. All Ethics
Committees waived the need for participants’ written informed
consent as this was a minimal-risk retrospective study, exclusively
based on data extraction from medical chart records, and it would
not be feasible to get patient’s consent for access to all charts.
According to Brazilian human research law, informed consent can
be waived in cases for which recording informed consent is not
possible, provided that a justification is registered and an Ethics
Committee gives approval. The data were analyzed anonymously.
Statistical Methods
Double data entry and validation were performed with Epi Info
software (CDC) and data analyses were conducted with SAS (SAS
Institute Inc., Cary, NC, USA). We described patients’ character-
istics using proportions, medians, and interquartile ranges.
Incidence of cardiac valve surgeries by age and etiology of
valvular dysfunction, as well as mortality rates per study year were
calculated based on the Brazilian Institute of Geography and
Statistics (IBGE) age-specific estimations for the population of
Salvador from 2002–2005 [12]. Age and etiology-specific
incidences of valve surgery were also stratified by payment source
(public versus private sector).
Characteristics of RHD patients and degenerative valve disease
patients were separately compared against all of the other patients.
Characteristics of patients who died prior to discharge were
compared with those of patients who survived in order to identify
risk factors for in-hospital death. Chi-square test or Fisher’s exact
test was used to compare proportions and the Wilcoxon Rank-
Sum test was used to compare continuous data. Statistically
significant differences were defined by two-tailed p-values less than
0.05. We used multivariable logistic regression modeling to
determine characteristics associated with surgeries due to RHD
in comparison to surgeries due to other etiologies of valve disease
and to evaluate risk factors for in-hospital death. Variables which
were statistically associated with death in univariable analyses and
those thought to influence disease severity, such as payment
source, underlying valvular dysfunction etiology, and prior heart
valve surgery, were included in a multivariable logistic regression
model.
Results
From January 1, 2002 to December 31, 2005, the six study
hospitals conducted 1,320 surgeries to repair or replace one or
more heart valves. Of these procedures, 540 (41%) were
conducted in residents of Salvador; medical charts of 491 (91%)
of these patients were reviewed. RHD was the underlying valve
disease etiology in 296 (60.3%) of the 491 patients whose medical
Burden of Heart Valve Disease Surgery in Brazil
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second most frequent etiology, found in 75 (15.3%) patients.
Endocarditis unrelated to RHD was the cause for 22 (4.5%) of all
surgeries. Other underlying valve disease etiologies combined
contributed to 45 (9.2%) surgeries. The diagnosis of the valve
diseases requiring surgery was not available for 53 (10.8%)
patients.
The mean annual incidence for all cardiac valve surgeries was
4.75 per 100,000 residents. The mean annual incidence of RHD,
degenerative valvular disease, and endocarditis unrelated to RHD
were 2.86, 0.73, and 0.21 cases per 100,000 population,
respectively. No temporal trends in the overall or etiology-specific
annual incidence of cardiac valve surgery were observed during
the four-year study period (data not shown). Overall, the mean
annual incidence of cardiac valve surgery was positively associated
with age.
For RHD, age-specific incidence followed a bimodal distribu-
tion determined by the source of surgery payment. RHD
incidence increased almost linearly by one case per 100,000
population for each decade of life until 40–49 years of age, peaking
at 4.85 cases per 100,000 population. Following a decline, a
second peak occurred for those at 60–69 years of age (6.54 cases
per 100,000 population) (Figure 1A). In the bimodal distribution,
the first incidence peak was comprised of patients 30–59 years of
age who had RHD surgery paid for by SUS (Figure 1B). The
second incidence peak was comprised of patients 60–79 years of
age who underwent RHD surgery paid for by private health
insurance (Figure 1C).
Degenerative valve disease surgery incidence began to increase
after 50 years of age and peaked at 70–79 years of age at 12.31
cases per 100,000 population (Figure 1A). Of note, the degener-
ative valve surgery incidence among those .70 years of age was
three times higher for surgeries paid by the private sector than for
surgeries paid by the public sector (9.00 versus 2.84 per 100,000
population, respectively [Figure 1B and 1C]).
The mean annual in-hospital mortality rate was 0.56 per
100,000 population. The mean annual in-hospital mortality due to
surgery for RHD, degenerative valve disease, and endocarditis
unrelated to RHD were 0.25, 0.13, and 0.07 cases per 100,000
population, respectively.
The median age for RHD patients was 37 years (interquartile
range [IQR]: 25–48 years); 153 (61%) were black or mixed race;
207 (71%) had the surgery paid by the public health system
(Table 2). In contrast, degenerative valvular disease patients had a
median age of 69 years (IQR: 63–77 years); 28 (43%) were black
or mixed and 23 (32%) had the surgery paid by the public health
system. Of those who had RHD surgery, 175 (60%) had mitral
valve involvement only, 53 (18%) had aortic valve disease only,
and 35 (12%) had both. In comparison, of those who had
degenerative disease, 29 (39%) had mitral valve disease only, 36
(48%) had aortic valve disease alone, and 6 (8%) had both.
Of patients with available data, 208 (50%) received a biological
prosthesis, 144 (35%) received a mechanical prosthesis, and 70
(17%) had a valve repair surgery (percentages sum was greater
than 100%; patients underwent distinct surgical procedures in two
or more valves; Table 2). Among RHD patients, 105 (43%) and
107 (44%) received mechanical and biological prostheses, respec-
tively. In those with degenerative disease, 48 (72%) and 8 (12%)
received mechanical and biological prostheses, respectively.
Among RHD patients, 55 (19%) underwent multiple-valve
surgery; of degenerative disease patients, 10 (13%) underwent
multiple-valve surgery (Table 2). Among RHD patients, 88 (30%)
had evidence of prior valve surgery compared with 1 (1%) among
the degenerative valve disease patients, and 1 (5%) among the
endocarditis patients. Of patients with history of previous heart
valve surgery, (98%) had RHD as the underlying valve disease.
Multivariable analysis controlling for sex found that patients
who underwent surgery for RHD were more likely to be younger
(odds ratio [OR]: 0.93 per year of age; 95% confidence interval
[CI]: 0.91–0.94), having the surgery paid by the public health
system (OR: 2.74; 95% CI: 1.61–4.68), and having had a prior
heart valve surgery (OR: 53.76; 95% CI: 11.80–244.96) in
comparison to patients operated due to other etiologies for the
valve disease (Table S1).
Overall, the in-hospital case fatality ratio was 12%. The in-
hospital case fatality ratio for patients who underwent surgery of
the mitral valve only, aortic valve only, and at more than one valve
was 10%, 8%, and 22%, respectively. Patients with a prior history
of heart valve surgery had a death risk of 15%. The case fatality
ratio was 9% for RHD patients, 17% for degenerative valvular
disease patients, and 32% for endocarditis patients (Table 2).
Multivariable analyses including age, sex, surgery payment
source, underlying valve disease etiology, number of operated
valves, and history of prior heart valve surgery found that the
likelihood of in-hospital death following a cardiac valve surgery
increased 4% (OR: 1.04; 95% CI: 1.02–1.06) for every year of
increase in age, was six times higher for patients with endocarditis
as the underlying valve disease (OR: 6.35; 95% CI: 1.92–21.04),
were four times higher for patients undergoing surgery in two or
more valves (OR: 4.35; 95% CI: 2.12–8.95), and 2.5 times higher
for patients with a prior history of heart valve surgery (OR: 2.49;
95% CI: 1.05–5.87) (Table 3). None of the hospitals was associated
with increased in-hospital death (data not shown).
Discussion
Despite recent socioeconomic advancements, our findings show
that the epidemiology of valvular heart disease surgeries in Brazil
still more closely resembles that of developing countries than that
Table 1. Mean annual incidence of open valvular heart
surgery according to underlying etiology for valve
dysfunction in Salvador, Brazil, 2002–2005.
Etiology Number (%) Incidence*
Total 491 (100.0) 4.75
Rheumatic heart disease
{ 296 (60.3) 2.86
Degenerative valvular disease
{ 75 (15.3) 0.73
Endocarditis 22 (4.5) 0.21
Dilated cardiomyopathy 11 (2.2) 0.11
Ruptured chordae tendineae 10 (2.0) 0.10
Congenital heart disease 7 (1.4) 0.07
Chagas disease 4 (0.8) 0.04
Aortic aneurism 4 (0.8) 0.04
Ischemic heart disease 3 (0.6) 0.03
Other
1 6 (1.2) 0.06
Unknown 53 (10.8) 0.51
*Mean annual incidence of open valvular heart surgery per 100,000 population.
{Includes 19 patients with rheumatic heart disease associated with endocarditis.
{Includes patients with calcific aortic stenosis and mitral annular calcification
related to aging.
1Includes one patient each with the following etiologies: mitral valve prolapse,
systemic lupus erythematosus, Wegener’s granulomatosis, Marfan syndrome,
alcoholic cardiomyopathy and traumatic injury.
doi:10.1371/journal.pone.0037855.t001
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four times more often than that for degenerative disease. In
developed countries, 60–70% of mitral regurgitation surgical
procedures are performed for degenerative disease and only 2–5%
are for RHD [13–16]. In this study, the mitral valve was the most
common valve operated on, and over 60% of these surgeries were
done to correct RHD-related valvular defect. As RHD typically
results from episodes of acute rheumatic fever acquired during
childhood, the high burden of RHD surgeries in the beginning of
the 21
st century in Salvador actually reflects a high rate of acute
rheumatic fever 20 to 30 years ago. Despite anecdotal reports of
reduction in the number of rheumatic fever hospitalizations in
Brazil, there is no good population-based evidence recording the
temporal trend in the rates of acute rheumatic fever and rheumatic
heart disease in the country.
As RHD persists in the population, the burden of surgeries for
degenerative valvular disease is expected to increase in the coming
years as the Brazilian population ages. From 1980 to 2010,
Brazilian life expectancy increased by more than ten years, from
62.7 to 73.4 years [10]. According to demographic projections for
Brazil, in 2050 life expectancy will be 81.3 years and 30% of the
population (64.1 million inhabitants) will be older than 60 years of
age [10].
We detected two different epidemiological patterns for heart
valve surgery occurrence. While RHD affected mainly the young
adult population without private health insurance, degenerative
valvular disease was the leading cause for valvular surgery among
those older than 60 years of age and with private health insurance.
These findings suggest that social inequities may be determining
both heart valve disease development, as well as access to heart
valve disease surgical care. Sustained actions to reduce social
inequalities will be necessary to decrease the risk of acute
rheumatic fever that ultimately leads to RHD and surgery among
the most vulnerable population. In addition, the low rates of
surgery for degenerative valve surgery paid by the public health
sector may suggest that the poor population have lower
opportunities for receiving surgical treatment for degenerative
valve disease. Improvements in the access to public health care will
be necessary to reduce morbidity and mortality from valvular
disease in poorer segments of the population.
In our study, 10% and 8% of the patients who underwent mitral
valve only and aortic valve only surgery died before hospital
discharge, respectively. These case fatality ratios are high,
particularly when considering the young age of the studied
patients. In the United States, several large studies documenting
death during hospitalization observed case fatality ratios ranging
between 6% and 9% after surgery of mitral valve only, and
between 4% and 6% after surgery of aortic valve only [17–19].
However, in these studies, the mean age ranged between 60–67
years for mitral valve surgeries and between 63–70 years for aortic
valve surgeries; the mean age of the patient population in Salvador
was 46 years for mitral valve surgery only and 55 years for aortic
valve surgery only.
This disparity in risk of death may be due to delayed diagnosis
and repeated surgical interventions especially for the RHD
patients with SUS. Surgeries performed late in the course of
Figure 1. Mean annual incidence of valvular surgery for
rheumatic heart disease (RHD) and degenerative valvular
disease as the underlying etiology of the valve dysfunction
per 100,000 population, according to age and payment source.
A. Incidence calculated for all surgeries. B. Incidence calculated for
surgeries paid by the public health sector. C. Incidence calculated for
surgeries paid by the private sector.
doi:10.1371/journal.pone.0037855.g001
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by the public health sector, but not the hospital where the surgery
was performed, was marginally associated with in-hospital death in
multivariable analysis reinforces the hypothesis that patients
operated by the public health sector had a more advanced valve
disease than those operated by the private sector.
In this study, 46% of patients less than 30 years of age received
biologic prostheses. These patients will need at least one and likely
several re-operative procedures over their lifetime. In this study,
having one or more previous surgeries doubled the risk of death.
This burden will almost exclusively affect RHD patients, who
constituted 98% of the population with previous surgery.
Valvular replacements or repairs are usually deferred for
patients with moderate to severe disease. Although our incidence
estimates may correctly reflect the burden of cardiac valvular
surgeries in Salvador, they underestimate the true burden of
cardiac valvular diseases. Those referred to surgery may represent
those with greater access to care and those with moderate to severe
disease. In contrast, they may under-represent those who have
already developed end-stage severe disease and were not able to be
surgically treated before death occurs. In addition, there is likely to
be a substantial number of individuals in Salvador with mild to
moderate and undiagnosed valvular disease. A survey of the
community using echocardiography would be needed to establish
the true prevalence of cardiac valvular disease in this population.
Unlike degenerative valvular disease, RHD can be prevented
through appropriate antibiotic prophylactic strategies. When
implemented effectively, the burden of end-stage disease and the
associated costs can be significantly reduced through register-
based secondary prophylaxis programs. Further investment in
planning and resources for secondary prophylaxis would be a cost
and life-saving strategy not just for the Brazilian population but for
others in developing and emerging economy nations [20].
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